Zoetis Medicated feed additives — Revenue increased by 140.0% to $12.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 76.5%, from $51.00M to $12.00M. Over 4 years (FY 2021 to FY 2025), Medicated feed additives — Revenue shows a downward trend with a -49.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests growing demand for livestock health management and successful market penetration in the production animal segment, while a decrease may indicate market contraction, increased competition, or a strategic shift away from feed-based health solutions.
This metric represents the total revenue generated from the sale of medicated feed additives, which are pharmaceutical o...
Comparable to animal health segments focused on livestock nutrition and preventative medicine at peer firms like Elanco or Merck Animal Health.
zts_segment_medicated_feed_additives_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $103.00M | $99.00M | $106.00M | $98.00M | $85.00M | $78.00M | $99.00M | $87.00M | $84.00M | $86.00M | $97.00M | $77.00M | $74.00M | $91.00M | $51.00M | $5.00M | $5.00M | $5.00M | $12.00M |
| QoQ Change | — | -3.9% | +7.1% | -7.5% | -13.3% | -8.2% | +26.9% | -12.1% | -3.4% | +2.4% | +12.8% | -20.6% | -3.9% | +23.0% | -44.0% | -90.2% | +0.0% | +0.0% | +140.0% |
| YoY Change | — | — | — | — | -17.5% | -21.2% | -6.6% | -11.2% | -1.2% | +10.3% | -2.0% | -11.5% | -11.9% | +5.8% | -47.4% | -93.5% | -93.2% | -94.5% | -76.5% |